Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Considering buying NFLX stock? Here’s what analysts think: Read This Next: Photo via ShutterstockLoading...Loading... ...

First Horizon Corporation (NYSE:FHN) will release earnings results for the third quarter, before the opening bell on Wednesday, Oct. 15.Analysts expect the Memphis, Tennessee-based company to report quarterly earnings at 45 cents per share, up from 42 cents per share in the year-ago period. First Horizon projects quarterly revenue of $847.99 million, compared to $832 million a year earlier, according to data from Benzinga Pro.On Aug. 15, First Horizon announced that Shaun McDougall has joined the organizati ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying CRH stock? Here’s what analysts think: Read This Next: Photo via ShutterstockLoading...Loading... ...

U.S. stocks settled higher on Friday, with the Dow Jones index gaining around 300 points during the session following the release of inflation data.Major indices, however, recorded losses last week, with the Nasdaq Composite falling 0.7% and S&P 500 losing 0.3%. The Dow also fell 0.2% during the week.Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one sin ...

Group 1 - Cintas Corporation is set to release its first-quarter earnings on September 24, with analysts expecting earnings of $1.2 per share, an increase from $1.1 per share in the same period last year [1] - The company's quarterly revenue is projected to be $2.7 billion, up from $2.5 billion a year earlier [1] - Cintas has increased its quarterly cash dividend from 39 cents to 45 cents as of July 29 [1] Group 2 - Cintas shares experienced a slight decline of 0.2%, closing at $199.51 [2] - Analysts have provided various ratings and price targets for Cintas, with RBC Capital setting a target of $240, Baird at $230, Morgan Stanley at $220, JP Morgan at $239, and Wells Fargo at $221 [7]

Group 1 - Top Wall Street analysts have revised their outlook on several prominent companies, indicating potential shifts in investment strategies [1] - Analysts are particularly focused on AON stock, suggesting it may be a viable investment option based on recent evaluations [1]

RH RH will release earnings results for the second quarter, after the closing bell on Thursday, Sept. 11.Analysts expect the Corte Madera, California-based company to report quarterly earnings at $3.22 per share, up from $1.69 per share in the year-ago period. RH is projected to report quarterly revenue of $905.36 million, compared to $829.65 million a year earlier, according to data from Benzinga Pro.On June 12, RH reported better-than-expected first-quarter adjusted EPS results and announced it is maintai ...

Group 1 - Tapestry, Inc. is set to release its fourth-quarter earnings results on August 14, with analysts expecting earnings of $1.02 per share, an increase from $0.92 per share in the same period last year [1] - The projected quarterly revenue for Tapestry is $1.68 billion, compared to $1.59 billion a year earlier [1] - Tapestry's shares rose by 2.4% to close at $113.53 following a renewed multi-year collaboration with Gen Phoenix, a leader in eco-friendly recycled leather fibers [2] Group 2 - Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating and raised the price target from $92 to $125 [8] - UBS analyst Jay Sole maintained a Neutral rating and increased the price target from $73 to $112 [8] - B of A Securities analyst Lorraine Hutchinson downgraded the stock from Buy to Hold while raising the price target from $95 to $115 [8] - JP Morgan analyst Matthew Boss maintained an Overweight rating and raised the price target from $104 to $145 [8] - Raymond James analyst Rick Patel reiterated an Outperform rating and boosted the price target from $85 to $115 [8]

Core Insights - Abbott Laboratories is set to release its second-quarter earnings results on July 17, with expected earnings of $1.25 per share, an increase from $1.14 per share in the same period last year [1] - The company anticipates quarterly revenue of $11.02 billion, up from $10.38 billion a year earlier [1] - Abbott received FDA approval for its Tendyne™ transcatheter mitral valve replacement system, which positively impacted its stock price [2] Analyst Ratings - Morgan Stanley analyst David Lewis maintained an Equal-Weight rating and raised the price target from $127 to $137 [5] - Raymond James analyst Jayson Bedford maintained an Outperform rating and increased the price target from $132 to $142 [5] - Barclays analyst Matt Miksic maintained an Overweight rating and slightly raised the price target from $158 to $159 [5] - Stifel analyst Rick Wise maintained a Buy rating and increased the price target from $135 to $145 [5] - Jefferies analyst Matthew Taylor maintained a Hold rating and raised the price target from $135 to $137 [5]

Core Viewpoint - J.B. Hunt Transport Services, Inc. is expected to report stable earnings and revenue for the second quarter, maintaining figures from the previous year [1] Financial Performance - For the second quarter, analysts anticipate earnings of $1.32 per share, unchanged from the same period last year [1] - Projected quarterly revenue is $2.93 billion, consistent with the previous year's revenue [1] - In the first quarter, J.B. Hunt reported a 7.6% decline in profit [2] Stock Performance - Following the first quarter results, J.B. Hunt Transport shares fell by 2.2%, closing at $149.56 [2] Analyst Ratings - Truist Securities maintained a Hold rating and raised the price target from $130 to $140 [4] - Susquehanna maintained a Neutral rating and increased the price target from $140 to $155 [4] - Goldman Sachs downgraded the stock from Buy to Neutral with a price target of $164 [4] - JP Morgan maintained an Overweight rating but cut the price target from $167 to $150 [4] - UBS maintained a Buy rating and reduced the price target from $196 to $155 [4]